How many studies have been conducted on Picibanil?

BiohacksAI has indexed 210 PubMed studies on Picibanil, including 12 randomized controlled trials (RCTs). 47% of studies involve human subjects.

What are the main research areas for Picibanil?

The primary research domains for Picibanil are 🔬 Oncology, 🛡️ Immunity, 🔬 Inflammation. This is based on analysis of 210 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Picibanil

A lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity.

210+ PubMed studies analyzed · 12 RCTs · Evidence Score: 47.6

Research Domains

Picibanil has been studied across 15 research domains including 🔬 Oncology, 🛡️ Immunity, 🔬 Inflammation, 🧬 Hormones, ⏳ Longevity & Aging. The primary research focus is 🔬 Oncology with 57% of studies addressing this area.

Loading evidence profile...

This evidence profile for Picibanil is generated deterministically from 210 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.